Sinovac appoints Kenneth Lee to its board
This article was originally published in Scrip
Sinovac Biotech, a provider of biopharmaceutical products in China, has appointed Kenneth Lee to its board of directors to replace Xianping Wang. Mr Lee has been a principalat growth capital fund, SAIF Partners since 2007 and has more than 15 years' experience in private equity investment, corporate finance and business development in China.